Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 5
2010 6
2011 2
2012 4
2013 3
2014 4
2015 4
2016 6
2017 12
2018 8
2019 7
2020 6
2021 8
2022 4
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Correspondence on 'Current myositis clinical trials and tribulations' by Saygin et al.
Azevedo SF, Valenzuela A, Benitez CA, Isenberg DA, Naddaf E, Chinoy H, Vencovský J, Gupta L, McCann L, Kuwana M, Dimachkie MM, Shenoi S, Saketkoo LA, Machado PM. Azevedo SF, et al. Among authors: mccann l. Ann Rheum Dis. 2024 Mar 28:ard-2024-225751. doi: 10.1136/ard-2024-225751. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38548314 No abstract available.
Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study.
Rodziewicz M, Dyball S, Lunt M, McDonald S, Sutton E, Parker B, Bruce IN; British Isles Lupus Assessment Group Biologics Register (BILAG-BR) consortium. Rodziewicz M, et al. Lancet Rheumatol. 2023 May;5(5):e284-e292. doi: 10.1016/S2665-9913(23)00091-7. Lancet Rheumatol. 2023. PMID: 38251591 Free article.
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: Results from the MYONET registry.
Hum RM, Lilleker JB, Lamb JA, Oldroyd AGS, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Danieli MG, Oakley P, Griger Z, Phuong TNT, Kodishala C, Vazquez-Del Mercado M, Andersson H, De Paepe B, De Bleecker JL, Maurer B, McCann L, Pipitone N, McHugh N, New RP, Ollier WE, Krogh NS, Vencovsky J, Lundberg IE; MYONET registry; Chinoy H. Hum RM, et al. Among authors: mccann l. Rheumatology (Oxford). 2023 Sep 12:kead481. doi: 10.1093/rheumatology/kead481. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37698987 Free article.
Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis.
Saketkoo LA, Valenzuela A, Kim S, McCann LJ, Lood C, Wahezi DM, Werth VP, Yi B, Alexanderson H, Maillard S, Pilkington C, Fligelstone K, Limbach B, Orandi AB, Regardt M, Russell AM, Davuluri S, deGroot I, Ernste F, Paik JJ, von Muhlen CA, Dimachkie MM, Machado PM, Naddaf E, Shafranski BM, Gupta L, Zulian F, Chung L; International Myositis Assessment and Clinical Studies Group and The Myositis International Research and Health Collaborative Alliance (IMACS/MIHRA) Calcinosis Scientific Interest Group. Saketkoo LA, et al. Among authors: mccann lj. Rheumatology (Oxford). 2024 May 2;63(5):1189-1191. doi: 10.1093/rheumatology/kead331. Rheumatology (Oxford). 2024. PMID: 37449887 No abstract available.
75 results